Tirzepatide 60mg

Tirzepatide – 60mg

Tirzepatide is a novel dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist that has attracted significant scientific interest for its effects on metabolic regulation. It represents a new class of incretin-based research compounds with a unique dual-receptor mechanism of action.

Product Specifications

• Peptide: Tirzepatide
• Quantity: 60mg per vial
• Purity: ≥99% (HPLC verified)
• Form: Lyophilised powder
• Storage: Store at -20°C. Protect from light and moisture.

Research Applications

Tirzepatide has been extensively studied in the context of metabolic disease, insulin sensitivity, and body weight regulation. As a dual GIP/GLP-1 receptor agonist, it is of particular interest to researchers investigating incretin biology, pancreatic beta-cell function, and adipose tissue metabolism.

For research use only. Not for human consumption. This product is intended solely for use in laboratory and scientific research settings by qualified professionals.